Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Arch Capital Investors – Latest Updates on ACGL Stock

Shares of Finance sector company Arch Capital moved -0.1% today, and are now trading at a price of $90.63. The Large-Cap stock's daily volume was 180,829 compared to its average volume of 2,371,661. The S&P 500 index returned a -1.0% performance.

Arch Capital Group Ltd., together with its subsidiaries, provides insurance, reinsurance, and mortgage insurance products in the United States, Canada, Bermuda, the United Kingdom, Europe, and Australia. The company is based in Pembroke and has 7,200 full time employees. Its market capitalization is $33,824,954,368.

16 analysts are following Arch Capital and have set target prices ranging from $93.0 to $125.0 per share. On average, they have given the company a rating of buy. At today's prices, ACGL is trading -16.33% away from its average analyst target price of $108.31 per share.

Over the last year, ACGL shares have gone down by -19.4%, which represents a difference of -34.9% when compared to the S&P 500. The stock's 52 week high is $116.47 per share and its 52 week low is $82.49. With average free cash flows of $4.05 Billion that have been growing at an average rate of 22.2% over the last 5 years, Arch Capital declining stock performance may not be reflective of the quality of its underlying business.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2024 6,673,000 51,000 6,622,000 16.24
2023 5,749,000 52,000 5,697,000 51.27
2022 3,816,000 50,000 3,766,000 11.29
2021 3,425,000 41,000 3,384,000 18.88
2020 2,886,505 39,872 2,846,633 41.58
2019 2,048,459 37,837 2,010,622
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS